4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-046905
Chief Scientific Officer sold 6,000 shares at $7.32 ($43,895)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2023-08-21 | Sale 10b5-1 | −6,000 | $7.32 | $43,895 | 135,724 | D |
| Open-market sales · 6,000 sh · avg $7.32 · $43,895 | |||||||
Loading xslF345X05/doc4.xml…